The Lancet Primary Care in conversation with
Thijs Jansz and John Dennis discuss their Article exploring the comparative effectiveness of GLP-1 receptor agonists versus other agents for kidney outcomes in individuals with type 2 diabetes taking SGLT2 inhibitors, including real-world implications and potential next steps. Click here to read the full article: https://www.thelancet.com/journals/lanprc/article/PIIS3050-5143(26)00034-8/fulltext [https://www.thelancet.com/journals/lanprc/article/PIIS3050-5143(26)00034-8/fulltext?dgcid=podcast_acq-may-2026_lanprc]
12 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The Lancet Primary Care in conversation with!